Hematology Reagents and Analyzer
Closed Solicitation Posted
This opportunity was awarded. See the award notice from .
- Solicitation number
- W81K0223Q0146
- Agency
- Medical Command Department of the Army, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Place of performance
- Korea, South
Notice details come from SAM.gov. Updated .
About this opportunity
This solicitation seeks monthly deliveries of hematology reagents and an analyzer to meet the needs of the 51st Medical Group at Osan Air Force Base in Korea. The Department of the Army Medical Command seeks to award a firm-fixed-price contract for an initial base period from September 2023 through September 2024, with four 12-month option periods extending through September 2027. Proposals are due by August 14, 2023 and will be evaluated for price and compliance with the terms of the solicitation.
There is no set-aside designation. The primary NAICS code is 325413 and PSC code is 6550, with performance to take place in South Korea. The solicitation involves supplying one hematology analyzer initially along with monthly reagents for the base year and four option years, totaling a possible five-year ordering period. Delivery locations and points of contact are identified to facilitate timely provision of the goods and adherence to quality and schedule requirements.
Notice text
3 versions
Update #3 · Latest ·
AMENDMENT 0002: The purpose of this amendment is to delete Option Period IV, period of performance is 01 October 2026 to 30 September 2027. FAR 52.217-9 OPTION TO EXTEND THE TERM OF THE CONTRACT has been revised to change the maximum number of months in the total duration of the contract from 49 to 37 months. See Solicitation W81K0223Q0146_Amendment 0002withAttach1 in SAM.gov.
The due date for receipt of quotations remains unchanged.
**************************************************************************************************************************************************
AMENDMENT 0001: The purpose of this amendment is to provide responses to questions received by the Contracting Office and to revise the Statement of Work, paragraphs 5.3.3 and 5.3.4. See Solicitation W81K0223Q0146_Amendment 0001withAttach1 in SAM.gov. The due date for receipt of quotations remains unchanged.
1. Responses to questions received by the contracting office.
Question #1: In regards to SOW paragraph 5.3.3, “with automated six part differential, and Platelet F estimates” is unique to the Sysmex technology and methodology to make the final test items of the government requirement in Para. 5.1. Is it possible to revise from “with automated six part differential, red blood cell indices, automated reticulocyte count, and platelet and Platelet F estimates on routine patient samples” to “with, red blood cell indices, automated reticulocyte count, and platelet on routine patient samples” or delete “automated six part differential”, and delete “Platelet F estimates”?
Response#1: Paragraph 5.3.3 has been revised to delete "Platelet F". No other changes to this paragraph.
Question #2: The requirements of SOW paragraph 5.3.4. Para 1, “Fluorescence flow cytometry and DC Impedance method” is the Sysmex internal technology only to make the final output items of the government requirement in Para. 5.1. Also, paragraph “5.3.4 Shall employ an enhanced multi-dimensional high-definition cellular analysis solution utilizing Fluorescence flow cytometry and DC Impedance method with hydrodynamic focusing technology.”
Response #2: Paragraph 5.3.4 has been revised as follows, "Shall employ an enhanced multi-dimensional high-definition cellular analysis solution utilizing flow cytometry."
Question #3: If the government wants to purchase the Sysmex hematology analyzer only, Please let me know the model No. of Sysmex hematology analyzer or the equivalent
Response #3: In accordance with the solicitation, the government intends to issue an order to the responsible supplier whose quoatation conforming to the solicitation is technically acceptable and has the lowest evaluated price. This requirement is not a sole source.
Question #4: Is it possible to change the start date?
Response #4: The start date will remain as indicated on the solicitation.
**************************************************************************************************************************************************
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This annoucement constitutes the only solicitation; proposals are being requsted and a written solicitation will not be issued. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This annoucement constitutes the only solicitation; proposals are being requsted and a written solicitation will not be issued.
The Medical Readiness Contracting Office - Pacific, Bldg 339 146 Clark Road, Ft Shafter, HI 96858, intends to solicit, negotiate, if necessary, and award a firm fixed-price contract for Hematology Reagenrts and Analyzers and contract with Firm Fixed-Prices for for the Osan Air Force Base, Korea for the period on or about 01 September 2023 to 30 September 2027. This is a request for quotation (RFQ). The solicitation number is W81K0223Q0146. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2023-04. The Standard Industrial Classification Code is 6550, size standard is 1250 employees and the NAICS code of 325413.
NOTICE TO QUOTERS:
All sources may submit a quote as applicable. However, the Republic of Korea (ROK)-United States (U.S.) Status of Forces Agreement (SOFA), may preclude the U.S. Government from granting Invited Contractor or Technical Representative Status to any quoters, for this requirement. All sources submitting a quote, including U.S. sources, must already have OR confirm their ability to obtain the requisite business licenses directly from the ROK Government, and conduct business in accordance with all applicable ROK laws, including but not limited to, rules and policies regarding labor, taxation, and immigration.
If an initial quote does not fully demonstrate this authorization and capacity, it will not be further considered for award.
Whether a quoter demonstrates this authorization and capacity shall be determined by the Contracting Officer.
Provision at 52.212-1, Instructions to Offerors -- Commercial, and its addendum applies to this acquisition and a statement regarding any addenda to the provision.
Provision at 52.212-2 Evaluation - Commercial Items and its addendum applies to this acquisition.
Offerors shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications -- Commercial Items, with its offer.
The clause at 52.212-4, Contract Terms and Conditions -- Commercial Items, and its addendum applies to this acquisition.
The deviation to clause at 52.212-5, Contract Terms and Conditions Required To Implement Statutes Or Executive Orders -- Commercial Items, applies to this acquisition. FAR clauses that are applicable to this acquisition are in the attachment to the combined synopsis/solicitation.
The Defense Priorities and Allocations System (DPAS) and assigned rating is not applicable.
The Government intends to award firm fixed-price contract to the successful quoter.
Contract Requirements - The successful quoter shall be required to meet the requirements of the combined synopsis/solicitation attachment.
Questions regarding the combination synopsis/solicitation shall be emailed to the POC below no later than August 7, 2023; 10:00 AM (HST).
Point of contact for this solicitation is Susan Fujita; 808-438-5113; email: susan.m.fujita.civ@health.mil
Quotations must be received by 14 August 2023 @ 10:00 AM HST.
***SEE ATTACHMENT SOLICITATION W81K0223Q0146withAttach1 FOR DELIVERY AND ACCEPTANCE, CONTRACT LINE ITEMS, AND TERMS AND CONDITIONS***
Update #2 ·
AMENDMENT 0001: The purpose of this amendment is to provide responses to questions received by the Contracting Office and to revise the Statement of Work, paragraphs 5.3.3 and 5.3.4. See Solicitation W81K0223Q0146_Amendment 0001withAttach1 in SAM.gov. The due date for receipt of quotations remains unchanged.
1. Responses to questions received by the contracting office.
Question #1: In regards to SOW paragraph 5.3.3, “with automated six part differential, and Platelet F estimates” is unique to the Sysmex technology and methodology to make the final test items of the government requirement in Para. 5.1. Is it possible to revise from “with automated six part differential, red blood cell indices, automated reticulocyte count, and platelet and Platelet F estimates on routine patient samples” to “with, red blood cell indices, automated reticulocyte count, and platelet on routine patient samples” or delete “automated six part differential”, and delete “Platelet F estimates”?
Response#1: Paragraph 5.3.3 has been revised to delete "Platelet F". No other changes to this paragraph.
Question #2: The requirements of SOW paragraph 5.3.4. Para 1, “Fluorescence flow cytometry and DC Impedance method” is the Sysmex internal technology only to make the final output items of the government requirement in Para. 5.1. Also, paragraph “5.3.4 Shall employ an enhanced multi-dimensional high-definition cellular analysis solution utilizing Fluorescence flow cytometry and DC Impedance method with hydrodynamic focusing technology.”
Response #2: Paragraph 5.3.4 has been revised as follows, "Shall employ an enhanced multi-dimensional high-definition cellular analysis solution utilizing flow cytometry."
Question #3: If the government wants to purchase the Sysmex hematology analyzer only, Please let me know the model No. of Sysmex hematology analyzer or the equivalent
Response #3: In accordance with the solicitation, the government intends to issue an order to the responsible supplier whose quoatation conforming to the solicitation is technically acceptable and has the lowest evaluated price. This requirement is not a sole source.
Question #4: Is it possible to to change the start date?
Response #4: The start date will remain as indicated on the solicitation.
**************************************************************************************************************************************************
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This annoucement constitutes the only solicitation; proposals are being requsted and a written solicitation will not be issued. This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This annoucement constitutes the only solicitation; proposals are being requsted and a written solicitation will not be issued.
The Medical Readiness Contracting Office - Pacific, Bldg 339 146 Clark Road, Ft Shafter, HI 96858, intends to solicit, negotiate, if necessary, and award a firm fixed-price contract for Hematology Reagenrts and Analyzers and contract with Firm Fixed-Prices for for the Osan Air Force Base, Korea for the period on or about 01 September 2023 to 30 September 2027. This is a request for quotation (RFQ). The solicitation number is W81K0223Q0146. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2023-04. The Standard Industrial Classification Code is 6550, size standard is 1250 employees and the NAICS code of 325413.
NOTICE TO QUOTERS:
All sources may submit a quote as applicable. However, the Republic of Korea (ROK)-United States (U.S.) Status of Forces Agreement (SOFA), may preclude the U.S. Government from granting Invited Contractor or Technical Representative Status to any quoters, for this requirement. All sources submitting a quote, including U.S. sources, must already have OR confirm their ability to obtain the requisite business licenses directly from the ROK Government, and conduct business in accordance with all applicable ROK laws, including but not limited to, rules and policies regarding labor, taxation, and immigration.
If an initial quote does not fully demonstrate this authorization and capacity, it will not be further considered for award.
Whether a quoter demonstrates this authorization and capacity shall be determined by the Contracting Officer.
Provision at 52.212-1, Instructions to Offerors -- Commercial, and its addendum applies to this acquisition and a statement regarding any addenda to the provision.
Provision at 52.212-2 Evaluation - Commercial Items and its addendum applies to this acquisition.
Offerors shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications -- Commercial Items, with its offer.
The clause at 52.212-4, Contract Terms and Conditions -- Commercial Items, and its addendum applies to this acquisition.
The deviation to clause at 52.212-5, Contract Terms and Conditions Required To Implement Statutes Or Executive Orders -- Commercial Items, applies to this acquisition. FAR clauses that are applicable to this acquisition are in the attachment to the combined synopsis/solicitation.
The Defense Priorities and Allocations System (DPAS) and assigned rating is not applicable.
The Government intends to award firm fixed-price contract to the successful quoter.
Contract Requirements - The successful quoter shall be required to meet the requirements of the combined synopsis/solicitation attachment.
Questions regarding the combination synopsis/solicitation shall be emailed to the POC below no later than August 7, 2023; 10:00 AM (HST).
Point of contact for this solicitation is Susan Fujita; 808-438-5113; email: susan.m.fujita.civ@health.mil
Quotations must be received by 14 August 2023 @ 10:00 AM HST.
***SEE ATTACHMENT SOLICITATION W81K0223Q0146withAttach1 FOR DELIVERY AND ACCEPTANCE, CONTRACT LINE ITEMS, AND TERMS AND CONDITIONS***
Update #1 ·
This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6, as supplemented with additional information included in this notice. This annoucement constitutes the only solicitation; proposals are being requsted and a written solicitation will not be issued.
The Medical Readiness Contracting Office - Pacific, Bldg 339 146 Clark Road, Ft Shafter, HI 96858, intends to solicit, negotiate, if necessary, and award a firm fixed-price contract for Hematology Reagenrts and Analyzers and contract with Firm Fixed-Prices for for the Osan Air Force Base, Korea for the period on or about 01 September 2023 to 30 September 2027. This is a request for quotation (RFQ). The solicitation number is W81K0223Q0146. The solicitation document and incorporated provisions and clauses are those in effect through Federal Acquisition Circular 2023-04. The Standard Industrial Classification Code is 6550, size standard is 1250 employees and the NAICS code of 325413.
NOTICE TO QUOTERS:
All sources may submit a quote as applicable. However, the Republic of Korea (ROK)-United States (U.S.) Status of Forces Agreement (SOFA), may preclude the U.S. Government from granting Invited Contractor or Technical Representative Status to any quoters, for this requirement. All sources submitting a quote, including U.S. sources, must already have OR confirm their ability to obtain the requisite business licenses directly from the ROK Government, and conduct business in accordance with all applicable ROK laws, including but not limited to, rules and policies regarding labor, taxation, and immigration.
If an initial quote does not fully demonstrate this authorization and capacity, it will not be further considered for award.
Whether a quoter demonstrates this authorization and capacity shall be determined by the Contracting Officer.
Provision at 52.212-1, Instructions to Offerors -- Commercial, and its addendum applies to this acquisition and a statement regarding any addenda to the provision.
Provision at 52.212-2 Evaluation - Commercial Items and its addendum applies to this acquisition.
Offerors shall include a completed copy of the provision at 52.212-3, Offeror Representations and Certifications -- Commercial Items, with its offer.
The clause at 52.212-4, Contract Terms and Conditions -- Commercial Items, and its addendum applies to this acquisition.
The deviation to clause at 52.212-5, Contract Terms and Conditions Required To Implement Statutes Or Executive Orders -- Commercial Items, applies to this acquisition. FAR clauses that are applicable to this acquisition are in the attachment to the combined synopsis/solicitation.
The Defense Priorities and Allocations System (DPAS) and assigned rating is not applicable.
The Government intends to award firm fixed-price contract to the successful quoter.
Contract Requirements - The successful quoter shall be required to meet the requirements of the combined synopsis/solicitation attachment.
Questions regarding the combination synopsis/solicitation shall be emailed to the POC below no later than August 7, 2023; 10:00 AM (HST).
Point of contact for this solicitation is Susan Fujita; 808-438-5113; email: susan.m.fujita.civ@health.mil
Quotations must be received by 14 August 2023 @ 10:00 AM HST.
***SEE ATTACHMENT SOLICITATION W81K0223Q0146withAttach1 FOR DELIVERY AND ACCEPTANCE, CONTRACT LINE ITEMS, AND TERMS AND CONDITIONS***
Attachments
| File | Type | Posted |
|---|---|---|
| W81K0223Q0146_Amendment 0002withAttach1.pdf | ||
| Solicitation W81K0223Q0146_Amendment 0001withAttach1.pdf | ||
| Solicitation W81K0223Q0146withAttach1.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Hematology Reagents and Analyzer | Award Notice | |
| Hematology Reagents and Analyzer | Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity